<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04078880</url>
  </required_header>
  <id_info>
    <org_study_id>SID-IRON</org_study_id>
    <nct_id>NCT04078880</nct_id>
  </id_info>
  <brief_title>Iron Supplementation in Hip/Knee Surgery (SIDERAL)</brief_title>
  <official_title>Sideral Forte in Prosthetic Hip and Knee Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Galeazzi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Galeazzi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial to evaluate the efficacy of oral iron supplementation in reducing
      the prevalence of preoperative anemia in a cohort of 82 patients undergoing elective
      prosthetic hip or knee surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 4, 2018</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of blood hemoglobin levels</measure>
    <time_frame>Baseline and 30 days +/- 5 days</time_frame>
    <description>CHange of hemoglobin concentration (g/dl) from baseline and after 30 days +/- 5 days</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Orthopedic Disorder</condition>
  <condition>Hip Arthropathy</condition>
  <condition>Knee Arthropathy</condition>
  <condition>Anemia</condition>
  <condition>Iron Poor Blood</condition>
  <arm_group>
    <arm_group_label>Intervention (group A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who are subjected to the intervention, being iron plus ascorbic acid, other than the standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (group B)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients who are not subjected to the intervention and follow the standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sucrosomial iron plus ascorbic acid</intervention_name>
    <description>A number of 41 subjects are supplemented with 30 mg of iron plus 70 mg of ascorbic acid daily for 30+/-5 days before orthopedic surgery.</description>
    <arm_group_label>Intervention (group A)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females

          -  ASA 1, 2, or 3

          -  No neuropsychiatric conditions

          -  Acceptance of informed consent

          -  Elective prosthetic hip or knee surgery

        Exclusion Criteria:

          -  ASA 4

          -  Present or past neuropsychiatric conditions

          -  Hip or knee revision surgery

          -  Use of iron as dietary supplement

          -  Known erythrocytosis

          -  Incompatible hypersensitivities

          -  Iron metabolism disorders

          -  Lymphoproliferative disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Perazzo, MG</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Istituto Ortopedico Galeazzi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Istituto Ortopedico Galeazzi</name>
      <address>
        <city>Milano</city>
        <zip>20161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 2, 2019</study_first_submitted>
  <study_first_submitted_qc>September 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

